Bipolar Disorder Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
This trial has three separate groups. People may be considered for one of the following:
Group 1 – Behavioral Frontotemporal Dementia (bvFTD) group:
- Adults aged 18 or older of any sex who have been diagnosed with behavioral variant Frontotemporal Dementia based on current diagnostic standards
- People who are able and willing to provide signed consent to participate
Group 2 – Bipolar Disorder (BD) group:
- Adults aged 18 or older of any sex who have been diagnosed with bipolar disorder according to standard psychiatric diagnostic criteria (DSM-V)
- People who are able and willing to provide signed consent to participate
Group 3 – Healthy Comparison (HC) group:
- Adults aged 18 or older of any sex who have gone through a full diagnostic evaluation for a possible brain or psychiatric condition, and whose results showed no signs of memory or thinking problems and no mood disorders
- People who are able and willing to provide signed consent to participate
Who may not be able to join:
- People who have a diagnosis of Alzheimer's disease
- People who have other conditions that could interfere with the study, such as other neurological diseases or a history of substance or alcohol misuse
- People who have a condition involving inflammation in the body, such as an autoimmune disease or a tumour
- People who are pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Elio Scarpini, Professor, UOSD Malattie Neurodegenerative
Phone: 02 55035982
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Identification of ncRNA transcripts and a specific noncoding RNA profile in neuron-derived exosomes; Differences in brain structure in terms of white matter volumes; Differences in brain structure in terms of gray matter volumes; Differences in brain structure in terms of cortical gyrification; Differences in brain structure in terms of superficial cortical area; Differences in brain structure in terms of cortical thickness; Differences in brain metabolism; Differences in glutamatergic neurotransmission in the prefrontal-limbic cortex
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.